Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure

– Combined company to trade on Nasdaq under ticker “OKUR”

– Reneo announces 1-for-10 reverse split of common stock

IRVINE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM) (“Reneo”) today announced the results of the special meeting of its stockholders held on September 26, 2024. At the special meeting, Reneo’s stockholders voted in favor of all proposals, including the proposals required to complete the proposed merger of Reneo and OnKure, Inc. (“OnKure”).